Difference between revisions of "CG"
DarylThomas (talk | contribs) |
DarylThomas (talk | contribs) |
||
Line 42: | Line 42: | ||
===Conference Call Archive=== | ===Conference Call Archive=== | ||
Conference call minutes are partitioned into separate pages chronologically by work group meeting. | Conference call minutes are partitioned into separate pages chronologically by work group meeting. | ||
− | *[[CG WG Call Notes leading to | + | *[[CG WG Call Notes leading to 2012 January WGM|2012 January]] - San Antonio, TX |
− | *[[2011 September]] - San Diego, CA | + | *[[CG WG Call Notes leading to 2011 September WGM|2011 September ]] - San Diego, CA |
− | *[[2011 May]] - Lake Buena Vista, FL | + | *[[CG WG Call Notes leading to 2011 May WGM|2011 May]] - Lake Buena Vista, FL |
− | *[[2011 January]] - Sydney, Australia | + | *[[CG WG Call Notes leading to 2011 January WGM|2011 January]] - Sydney, Australia |
− | *[[2010 October]] - Cambridge, MA | + | *[[CG WG Call Notes leading to 2010 October WGM|2010 October]] - Cambridge, MA |
*2010 May - Rio de Janeiro, Brazil | *2010 May - Rio de Janeiro, Brazil | ||
*2010 January - Phoenix, AZ | *2010 January - Phoenix, AZ |
Revision as of 17:52, 27 September 2011
Main Page | Clinical Genomics (CG)
This page is for the Clinical Genomics Work Group
Contents
Mission and Charter
Mission
This group supports the HL7 mission to create and promote its standards by enabling the communication between interested parties of the clinical and personalized genomic data. The focus of clinical genomics work is the personalization (differences in individual's genome) of the genomic data and the linking to relevant clinical information.
This Work Group will facilitate the development of common standards for clinical research information management across a variety of organizations -- including national and international government agencies and regulatory bodies, private research efforts, and sponsored research -- and thus the availability of safe and effective therapies by improving the processes and efficiencies associated with regulated clinical research.
Charter
Work Products and Contributions to HL7 Processes
The Work Group will collect, review, develop and document clinical genomics use cases in order to determine what data needs to be exchanged. The WG will review existing genomics standards formats such as BSML (Bioinformatics Sequence Markup Language), MAGE-ML (Microarray and Gene Expression Markup Language), LSID (Life Science Identifier) and other. This group will recommend enhancements to and/or extensions of HL7's normative standards for exchange of information about clinical genomic orders and observations.
In addition, Clinical Genomics will seek to assure that related or supportive standards produced by other HL7 groups are robust enough to accommodate their use in both research and clinical care use. The group will also monitor information interchange standards developed outside HL7, and attempt harmonization of information content and representation of such standards with the HL7 content and representation.
Formal Relationships with Other HL7 Groups
This Work Group will coordinate with a large number of other Work Groups in order to accomplish its mission. Strongest relationships will be with:
- Orders and Observation
- Clinical Statement
- Clinical Decision Support
- Regulated Clinical Research Information Management
- Orders and Observations
- Patient Care
- Electronic Health Records
- Modeling and Methodology
- Structured Documents
Formal Relationships with Groups Outside of HL7
Decision Making
See Work Group Decision Making Documents[1] (Date of Last Revision: Final March 2, 2009)
Conference Calls, Agendas and Minutes
Web and Teleconference(default)
WebEx meeting links for the Tuesday 11 AM EST call have been sent out to the listserv. If you did not receive a meeting invite, please contact Grant Wood at grant.wood@imail.org.
NOTE: We sometimes schedule calls at noon US Eastern Time to work on project specific items. These special calls will also be listed in the Conference Call page as well.
Current Conference Call Agendas and Minutes
Conference call agendas and minutes leading up to the next HL7 Work Group Meeting are kept on this page: Conference Calls.
Conference Call Archive
Conference call minutes are partitioned into separate pages chronologically by work group meeting.
- 2012 January - San Antonio, TX
- 2011 September - San Diego, CA
- 2011 May - Lake Buena Vista, FL
- 2011 January - Sydney, Australia
- 2010 October - Cambridge, MA
- 2010 May - Rio de Janeiro, Brazil
- 2010 January - Phoenix, AZ
- 2009 September - Atlanta, GA
- 2009 May - Kyoto, Japan
- 2009 January - Lake Buena Vista, FL
- 2008 September - Vancouver, B.C., Canada
- 2008 May - Phoenix, Arizona
- 2008 January - San Antonio, TX
- 2007 September - Atlanta, GA
- 2007 May
- 2007 January
- 2006 September
- 2006 May
- 2006 January
CG Projects
Family History - Pedigree
Models - Domain Information and Domain Analysis
Genotype Topic
Genetic Variation
Gene Expression
Clinical Sequencing
Working Group Meetings
CG Working Group Meeting Agendas
CG Working Group Meeting Minutes
Sub-Teams
Domains
Clinical Genomics
Clinical Genomics Facilitators
Modeling:
Amnon Shabo shabo@il.ibm.com IBM Research Lab in Haifa
Publishing:
Grant Wood Grant.Wood@imail.org Intermountain Healthcare
Vocabulary:
Joyce Hernandez joyce_hernandez@merck.com
Standards
HL7 CGPED, R1-
- HL7 Version 3 Pedigree Topic - Family History
- Last Ballot: Normative Ballot 1 - May, 2007
HL7 CG_GV, R1
- HL7 Version 3 Standard: Genetic Variation, Release 1
- Last Ballot: Normative Ballot 2 - January 2009
HL7 IG CG_GENO, R1
- HL7 Version 3 Genotype, Release 1
- Last Ballot: DSTU Ballot 1 - January 2009
HL7 IG LOINCGENVA, R1
- HL7 Version 2 Implementation Guide: Clinical Genomics; Fully LOINC-Qualified Genetic Variation Model, Release 1 (US Realm)
Reference Links
BRIDG file release site http://gforge.nci.nih.gov/frs/?group_id=342
BRIDG Project site http://gforge.nci.nih.gov/projects/bridg-model/